[HTML][HTML] Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson… - Oncology …, 2017 - spandidos-publications.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
Repurposing itraconazole for the treatment of cancer.
R Pounds, S Leonard, C Dawson, S Kehoe - Oncology Letters, 2017 - europepmc.org
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
[PDF][PDF] Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson, S Kehoe - ONCOLOGY LETTERS, 2017 - core.ac.uk
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
[PDF][PDF] Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson, S Kehoe - Oncology Letters, 2017 - academia.edu
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
[HTML][HTML] Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson… - Oncology …, 2017 - spandidos-publications.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
[PDF][PDF] Repurposing itraconazole for the treatment of cancer
R POUNDS, S LEONARD… - ONCOLOGY …, 2017 - awarticles.s3.amazonaws.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson… - Oncology …, 2017 - search.ebscohost.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
Repurposing itraconazole for the treatment of cancer
R POUNDS, S LEONARD, C DAWSON… - ONCOLOGY …, 2017 - ingentaconnect.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
[PDF][PDF] Repurposing itraconazole for the treatment of cancer
R POUNDS, S LEONARD, C DAWSON, S KEHOE - researchgate.net
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
Repurposing itraconazole for the treatment of cancer
R Pounds, S Leonard, C Dawson, S Kehoe - Oncology Letters, 2017 - go.gale.com
The repurposing of drugs is becoming increasingly attractive as it avoids the lengthy process
and cost implications associated with bringing a novel drug to market. Itraconazole is a …
and cost implications associated with bringing a novel drug to market. Itraconazole is a …